CNO Financial Group, Inc.
Business
CNO Financial Group, Inc. is a holding company for insurance subsidiaries that develop, market and administer health insurance, annuities, individual life insurance and other insurance and financial services products. Its principal offerings include fixed indexed and fixed interest annuities, single premium immediate annuities, supplemental health, Medicare supplement, long‑term care, interest‑sensitive and traditional life products, and investment management services. The business is organized into three insurance product lines (annuity, health and life), plus investment and fee income segments, and operates Consumer and Worksite Divisions. CNO markets products across all 50 states, the District of Columbia and certain U.S. protectorates through exclusive agents, independent producers, direct marketing and workplace channels, and uses third‑party distributors for some direct‑to‑consumer sales.
Summary from filing dated 2025-02-26
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Insurance policy income | 2,623 | 2,559 | 2,506 | 2,500 | 2,523 | |
| General account assets | 1,542 | 1,419 | 1,250 | 1,179 | 1,140 | |
| Policyholder and other special-purpose portfolios | 181 | 329 | 250 | −163 | 281 | |
| Realized investment losses | −60 | −76 | −69 | −18 | 21 | |
| Other investment gains | 5 | 26 | 300,000 | −118 | −2 | |
| Total investment losses | −55 | −50 | −69 | −135 | 19 | |
| Fee revenue and other income | 196 | 192 | 211 | 197 | 159 | |
| Total revenues | 4,487 | 4,450 | 4,147 | 3,577 | 4,122 | |
| Insurance policy benefits | 2,548 | 2,450 | 2,331 | 1,617 | 2,188 | |
| Liability for future policy benefits remeasurement loss | −71 | −41 | −21 | −16 | −51 | |
| Change in fair value of market risk benefits | −12 | −61 | −34 | −142 | −23 | |
| Interest expense | 231 | 254 | 239 | 137 | 95 | |
| Amortization of deferred acquisition costs and present value of future profits | 278 | 251 | 227 | 213 | 198 | |
| Goodwill and other asset impairment | 102 | 0 | 0 | — | — | |
| Gain on extinguishment of borrowings related to variable interest entities | −2 | 0 | 0 | — | 0 | |
| Other operating costs and expenses | 1,120 | 1,055 | 1,048 | 951 | 982 | |
| Total benefits and expenses | 4,194 | 3,910 | 3,790 | 2,760 | 3,389 | |
| Income before income taxes | 293 | 540 | 357 | 817 | 733 | |
| Income tax expense | 64 | 119 | 80 | 186 | 163 | |
| Net income | 229 | 421 | 277 | 631 | 570 | |
| Weighted average shares outstanding (in shares) | 98 | 106 | 113 | 116 | 128 | |
| Net income (in USD per share) | 2.35 | 3.96 | 2.44 | 5.45 | 4.44 | |
| Weighted average shares outstanding (in shares) | 100 | 108 | 115 | 118 | 131 | |
| Net income (in USD per share) | 2.3 | 3.89 | 2.4 | 5.36 | 4.35 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Fixed maturities, available for sale, at fair value (net of allowance for credit losses: 2025 - $36.0 and 2024 - $37.1; amortized cost: 2025 - $25,776.4 and 2024 - $25,151.0) | 23,887 | 22,730 | 21,506 | 20,353 | 24,805 | |
| Equity securities at fair value | 389 | 272 | 97 | 135 | 131 | |
| Mortgage loans (net of allowance for credit losses: 2025 - $20.9 and 2024 - $13.6) | 3,257 | 2,506 | 2,064 | 1,412 | 1,219 | |
| Policy loans | 141 | 135 | 129 | 122 | 120 | |
| Trading securities | 295 | 304 | 223 | 208 | 227 | |
| Investments held by variable interest entities (net of allowance for credit losses: 2025 - $0.6 and 2024 - $1.3; amortized cost: 2025 - $294.1 and 2024 - $437.0) | 293 | 434 | 769 | 1,078 | 1,200 | |
| Other invested assets | 1,737 | 1,492 | 1,353 | 1,035 | 1,224 | |
| Total investments | 29,999 | 27,874 | 26,140 | 24,342 | 28,926 | |
| Cash and cash equivalents - unrestricted | 956 | 1,657 | 775 | 576 | 632 | |
| Cash and cash equivalents held by variable interest entities | 27 | 341 | 115 | 69 | 100 | |
| Accrued investment income | 286 | 286 | 252 | 236 | 216 | |
| Present value of future profits | 144 | 161 | 181 | 204 | 230 | |
| Deferred acquisition costs | 2,397 | 2,159 | 1,944 | 1,771 | 1,112 | |
| Reinsurance receivables (net of allowance for credit losses: 2025 - $1.0 and 2024 - $3.0) | 3,678 | 3,855 | 4,041 | 4,223 | 4,354 | |
| Income tax assets, net | 713 | 814 | 936 | 1,063 | 118 | |
| Assets held in separate accounts | 3 | 3 | 3 | 3 | 4 | |
| Other assets | 588 | 700 | 641 | 581 | 519 | |
| Total assets | 38,791 | 37,849 | 35,027 | 33,133 | 36,204 | |
| Policyholder account balances | 18,913 | 17,594 | 15,223 | 15,234 | 13,690 | |
| Future policy benefits | 11,898 | 11,706 | — | — | — | |
| Market risk benefit liability | 48 | 60 | 117 | 11 | — | |
| Liability for life insurance policy claims | 58 | 61 | 62 | 64 | 502 | |
| Unearned and advanced premiums | 228 | 227 | 219 | 235 | 247 | |
| Liabilities related to separate accounts | 3 | 3 | 3 | 3 | 4 | |
| Other liabilities | 953 | 1,163 | 849 | 694 | 831 | |
| Investment borrowings | 2,442 | 2,189 | 2,189 | 1,640 | 1,716 | |
| Borrowings related to variable interest entities | 274 | 498 | 821 | 1,105 | 1,148 | |
| Notes payable direct corporate obligations | 1,336 | 1,834 | 1,141 | 1,139 | 1,137 | |
| Total liabilities | 36,152 | 35,334 | 32,812 | 31,364 | 30,945 | |
| Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: 2025 - 94,484,339 and 2024 - 101,618,957) | 900,000 | 1 | 1 | 1 | 1 | |
| Additional paid-in capital | 1,336 | 1,633 | 1,892 | 2,034 | 2,184 | |
| Accumulated other comprehensive loss | −1,115 | −1,371 | −1,577 | −1,957 | 1,947 | |
| Retained earnings | 2,416 | 2,253 | 1,900 | 1,691 | 1,127 | |
| Total shareholders' equity | 2,638 | 2,515 | 2,216 | 1,769 | 3,685 | |
| Total liabilities and shareholders' equity | 38,791 | 37,849 | 35,027 | 33,133 | 36,204 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Insurance policy income | 2,403 | 2,348 | 2,285 | 2,300 | 2,342 | |
| Net investment income | 1,503 | 1,415 | 1,329 | 1,155 | 1,073 | |
| Fee revenue and other income | 180 | 169 | 205 | 149 | 143 | |
| Insurance policy benefits | −1,629 | −1,604 | −1,611 | −1,636 | −1,661 | |
| Interest expense | −230 | −259 | −233 | −121 | −93 | |
| Deferrable policy acquisition costs | −499 | −446 | −378 | −336 | −304 | |
| Other operating costs | −1,014 | −940 | −956 | −982 | −921 | |
| Income taxes | −38 | −55 | −59 | — | — | |
| Net cash provided by operating activities | 676 | 628 | 583 | 495 | 598 | |
| Sales of investments | 3,275 | 3,240 | 1,389 | 3,254 | 1,824 | |
| Maturities and redemptions of investments | 3,521 | 2,175 | 1,397 | 1,551 | 2,880 | |
| Purchases of investments | −8,460 | −6,803 | −3,592 | −6,482 | −6,135 | |
| Net purchases of trading securities | 0 | −88 | −29 | −42 | −20 | |
| Other, net | −3 | −14 | −37 | −61 | −75 | |
| Net cash used by investing activities | −1,667 | −1,489 | −872 | −1,781 | −1,526 | |
| Issuance of notes payable, net | 0 | 691 | 0 | 0 | 0 | |
| Payments on notes payable | −500 | 0 | 0 | — | 0 | |
| Issuance of common stock | 12 | 11 | 13 | 14 | 22 | |
| Payments to repurchase common stock | −331 | −300 | −166 | −190 | −408 | |
| Common stock dividends paid | −66 | −68 | −68 | −65 | −66 | |
| Amounts received for deposit products | 3,234 | 3,932 | 2,112 | 3,023 | 2,405 | |
| Withdrawals from deposit products | −2,386 | −1,962 | −1,696 | −1,461 | −1,353 | |
| Proceeds from financing arrangements | 0 | 0 | 80 | 0 | 0 | |
| Payments on financing arrangements | −15 | −14 | −6 | 0 | 0 | |
| Federal Home Loan Bank | 777 | 612 | 996 | 285 | 796 | |
| Related to variable interest entities | 0 | 276 | 0 | 0 | — | |
| Federal Home Loan Bank | −524 | −613 | −446 | −361 | −722 | |
| Related to variable interest entities and other | −223 | −597 | −285 | −44 | −5 | |
| Net cash (used) provided by financing activities | −23 | 1,970 | 534 | 1,199 | 668 | |
| Net (decrease) increase in cash and cash equivalents | −1,014 | 1,109 | 244 | −87 | −260 |
Filings
Material Events
Insiders
Institutional Holders
Holdings (13F)
Portfolio as of 2026-01-14 · 8 positions
Top sectors
| Sector | Value | % of portfolio |
|---|---|---|
| Uncategorized | $89.55M | 100.0% |
Top holdings
| Issuer | Ticker | Shares | Value | % |
|---|---|---|---|---|
| ISHARES TR | — | 727.1K | $36.73M | 41.0% |
| SPDR SER TR | — | 700.0K | $27.31M | 30.5% |
| INVESCO EXCH TRADED FD TR II | — | 619.7K | $18.39M | 20.5% |
| REDWOOD TR INC | — | 5.00M | $4.93M | 5.5% |
| GOLDMAN SACHS BDC INC | — | 2.00M | $2.00M | 2.2% |
| SELECTQUOTE INC | — | 50.5K | $141.0K | 0.2% |
| VMWARE INC | — | 349 | $40.0K | 0.0% |
| GOHEALTH INC | — | 10.0K | $12.0K | 0.0% |